Abstract
Race-based medicine is an emerging field in pharmacology, a field which aims to create a specialty market based on racial groups. Within this field, the drug BiDil set precedents for this area of medicine, targeting African Americans as its first racial group. Immediately, the idea of race as a proxy for disease caused much debate within the medical and pharmaceutical communities.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 The Author(s)
About this chapter
Cite this chapter
Johnson, K.A. (2019). Conclusion. In: Medical Stigmata. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-13-2992-0_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-2992-0_6
Published:
Publisher Name: Palgrave Macmillan, Singapore
Print ISBN: 978-981-13-2991-3
Online ISBN: 978-981-13-2992-0
eBook Packages: Social SciencesSocial Sciences (R0)